Flow Traders U.S.’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,134
Closed -$480K 1075
2022
Q1
$480K Sell
12,134
-2,809
-19% -$111K 0.02% 568
2021
Q4
$707K Buy
14,943
+10,391
+228% +$536K 0.04% 377
2021
Q3
$249K Sell
4,552
-18,322
-80% -$1.04M 0.01% 872
2021
Q2
$1.39M Buy
22,874
+5,651
+33% +$324K 0.07% 317
2021
Q1
$997K Buy
+17,223
New +$1.08M 0.05% 325

Other funds holding BTEC

Flow Traders U.S.'s BTEC Position: Q2 2022 in Review

Flow Traders U.S. sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q2 2022, closing a stake of 12,134 shares — an estimated $480K sold.

Flow Traders U.S. first reported a position in BTEC in Q1 2021 and held it in 5 quarters. The position peaked at $1.39M in Q2 2021. 23 funds tracked by Wall St. Rank hold BTEC as of Q2 2022.

  • Flow Traders U.S. reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q2 2022 after selling out during the quarter.
  • Flow Traders U.S. sold 12,134 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q2 2022, an estimated $480K.
  • Flow Traders U.S. first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2021 and held it in 5 quarters.
  • Flow Traders U.S.'s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $1.39M in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q2 2022.

Based on Flow Traders U.S.'s 13F filing for Q2 2022, filed 12 Aug 2022.